Karnataka

The Molecular Biophysics Unit (MBU) at the Indian Institute of Science was founded in 1971 by Prof. G. N. Ramachandran. The Unit is currently engaged in frontline research in contemporary Molecular Biophysics and Structural Biology.  The research activities in the Unit focus on the structure, conformation and interactions of biomolecules, with the main objective of explaining biological activity in molecular terms.  The unit has grown over a quarter of century, during this period, more than 200 young scientists have obtained their Ph.D. degrees and the number of research publications exceeds 1000. Seven faculty members have received prestigious S. S. Bhatnagar prize; eight members are fellows of the Indian Academy of Sciences and seven members are fellows of the Indian National Science Academy.

BPPI is the implementing agency for Pradhan Mantri Bhartiya Janaushadhi Pariyojana of Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India. The objective of the scheme is to make available quality generic medicines at affordable prices to all. BPPI is expanding its operations and has urgent requirements on various posts on contractual basis. Requirements are on below posts:

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post : Global Product Manager

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post : Regulatory Affairs Associate Analyst

PAREXEL has supported the Bio-Tech and Pharmaceutical industries in helping the development of new drugs and treatments on a global basis. As a leading global biopharmaceutical service provider, they supply knowledge-based contract research, medical communications and consulting services across a broad range of therapeutic areas to the worldwide pharmaceutical, biotechnology and medical device industries.

Post : Senior Regulatory Affairs Associate

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post : Regulatory Affairs Associate Analyst

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post : Analyst for Regulatory Affairs department

National Institute of Unani Medicine (NIUM) Bangalore is as an autonomous organization under the Ministry of AYUSH, Government of India working since 2004. This Institute is being developed as a model of post graduate, teaching, training and research in Unani System of Medicine.  The campus now houses an Academic Block, Hospital Building, Library, Pharmacy, Administrative Block, Herbal Garden, Animal House, Guest House, Indoor Games Hall, Hostels, Residential Blocks and several other units.

Karnataka Antibiotics & Pharmaceuticals Ltd., (KAPL) Bangalore is a Government Enterprise.  From a modest beginning in 1984, KAPL has grown from strength to strength in the areas of manufacturing and marketing of various life saving and essential drugs. With an ISO accredition from KPMG, Netherlands, KAPL is recognised for its total commitment to quality and services in domestic and international markets. On profit from inception, KAPL facilities are approved by many international clients.